Closing the Care Gap by Shaping the Future of Evidence-Based Medicine
Healthcare still lags behind other economic sectors in terms of digitalization. Despite significant advancements in diagnostic and therapeutic…
Supporting Multidisciplinary Approach to Cancer Diagnosis and Therapy
Patients rely on their providers for high-quality care that encompasses the most up-to-date recommendations for diagnosis and therapy. Integrated…
LMU Munich: Prospective study shows the suitability of a semi-automatic approach to assess changes in prostate MRI after prostatic artery embolization
A prospective, monocentric study [1] conducted by Vanessa F. Schmidt and her colleagues at the University Hospital Munich (LMU) evaluated the…
Fighting prostate cancer with AI and automatic segmentation
Advances in technology, especially in the field of AI, can significantly relieve the ever-increasing workload of radiologists today. We are…
mint Lesion™ 3.8. Release: What’s New?
The recent 3.8 release brings with it a multitude of new features and refinements that further facilitate reporting, interdisciplinary collaboration,…
Improving interdisciplinary communication when using PI-RADS v2.1
AI-powered quantification of bone metastasis in prostate cancer
Prostate cancer is the second most common cancer among men, and there are now effective treatments for the disease. New therapies available on the…
mint PI-RADS V2 report as the standard for communication with urologists - Interview with PD Dr. Röthke
Since the beginning of 2017, all PI-RADS v2 reads are exclusively performed with mint Lesion™ by PD Dr. Matthias Röthke, Chief Medical Officer at…
About Cookies
This website uses cookies. Those have two functions: On the one hand they are providing basic functionality for this website. On the other hand they allow us to improve our content for you by saving and analyzing anonymized user data. You can redraw your consent to using these cookies at any time. Find more information regarding cookies on our Data Protection Declaration and regarding us on the Imprint.
